A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases - Nature
Linafexor is a rapidly cleared FXR agonist designed to mimic natural bile acid signalling, achieving transient receptor activation with strong efficacy and reduced toxicity in preclinical and early clinical studies.